Legalzoom.Com, Inc.
LegalZoom Reports Third Quarter 2026 Financial Results
•Revenue of $195.1 million, up 3% year-over-year, above the midpoint of the Company’s guidance range
Source
From SEC EDGAR
180 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
Freshpet, Inc.
Freshpet, Inc. Reports Third Quarter 2026 Financial Results
Delivers 10% Net Sales Growth
Southwest Gas Holdings, Inc.
Southwest Gas Holdings, Inc. Reports Third Quarter 2026 Financial Results,
Reaffirms Full-Year 2026 Guidance
Marinemax Inc
MarineMax Reports Fiscal 2026 Fourth Quarter and Full Year Results
~Reports Fourth Quarter Revenue of $520.1 Million~
XPEL, Inc.
Ex. 99.1
XPEL Reports Revenue of $137.8 million; Revenue Growth of 9.9% in Third Quarter 2026
Trinity Capital Inc.
Trinity Capital Reports Third Quarter 2026 Financial Results
Return on Average Equity climbs to 15.5% in Q3
Ocugen, Inc.
Ocugen Provides Business Update with Third Quarter 2026 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET
Foster L B Co
FOSTER L B CO
SharkNinja, Inc.
SharkNinja Reports Third Quarter 2026 Results
Raises Fiscal Year 2026 Outlook Across Key Metrics on Strong Operational Performance
MoonLake Immunotherapeutics
MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update
•Biologics License Application for sonelokimab submitted to the U.S. Food and Drug Administration for the treatment of adults and adolescents with…
New York Times Co
The New York Times Company Reports Third-Quarter 2026 Results
Seres Therapeutics, Inc.
SERES THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND ANNOUNCES PLANS FOR ADVANCING DEVELOPMENT OF SER-155 TO PREVENT IMMUNE CHECKPOINT INHIBITOR-RELATED ENTEROCOLITIS (irEC)
Prevention approach aims to keep patients on immune checkpoint inhibitor (ICI) therapy and avoid immunosuppressive irEC treatments, representing an…